Common Stock, $0.001 par value
- Symbol
- DVA
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
DaVita Inc.
DVANYSEEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On May 5, 2026, DaVita Inc. (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report.…
Company context
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey - from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home.
Current securities
Registered securities in this filing
DAVITA INC. · 8-K · Filed 2026-05-05
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02. Results of Operations and Financial Condition.
On May 5, 2026, DaVita Inc. (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information contained in this Item 2.02 (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 2 dva33126ex991.htm EX-99.1 Document Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 1st Quarter 2026 Results Denver, Colorado, May 5, 2026 - DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2026. “DaVita’s foundation is clinical excellence, driven by operating rigor that produces durable results,” said Javier Rodriguez, CEO of DaVita Inc. “We have consistently delivered exceptional clinical outcomes and strong financial performance, and this quarter is no exception.” Financial and operating highlights for the quarter and year ended March 31, 2026: • Consolidated revenues were $3.416 billion. • Operating income was $482 million. • Diluted earnings per share from continuing operations was $2.87. • Operating cash flow was $321 million and free cash flow was $140 million. • Repurchased 3.0 million shares of the Company's common stock at an average price paid of $133.70 per share. Three months ended March 31, 2026 December …
Open exhibit ↗